TESARO (TSRO) Sets IPO Price Range at $12-$15/Share
Get Alerts TSRO Hot Sheet
Join SI Premium – FREE
TESARO, Inc. (Nasdaq: TSRO) filed an amended registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The company will offer 6 million shares in the range of $12-$15 per share. TESARO plans to list on the Nasdaq Global Market under the ticker "TSRO."
The offering is being made through Citigroup, Morgan Stanley, Leerink Swann, BMO Capital Markets, and Baird.
TESARO is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.
The offering is being made through Citigroup, Morgan Stanley, Leerink Swann, BMO Capital Markets, and Baird.
TESARO is an oncology-focused biopharmaceutical company dedicated to improving the lives of cancer patients.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fisker (FSR) files form 10-K, sees more job cuts, reiterates going concern doubts
- Bogota Financial (BSBK) Announces 237K Share Buyback
- YY Group Holding (YYGH) Closes $5M IPO
Create E-mail Alert Related Categories
IPOsRelated Entities
Citi, Morgan Stanley, Robert W Baird, BMO CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!